Shares of BioNTech saw a significant increase on Friday following positive results from a pivotal study of its experimental breast cancer treatment. The stock surged by 9% as the treatment met the predetermined success criteria. This promising development generated positive investor sentiment and was highlighted in a recent article from Investor's Business Daily.